LexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections
05 juil. 2022 07h55 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the...
LexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin
01 juil. 2022 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the...
LexaGene Announces Management Cease Trade Order
30 juin 2022 17h32 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”) announces, further to its news release on June 28, 2022, the...
LexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings
28 juin 2022 18h46 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”) announces that it has filed an initial registration statement with...
LexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health
25 mai 2022 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
LexaGene Successfully Completes CRADA with US Army
03 mai 2022 08h00 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the...
LexaGene Announces Multi-System Purchase from a Corporate Veterinary Reference Laboratory
25 avr. 2022 08h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., April 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
LexaGene Announces Advancements to its Sample Preparation Cartridge for the Veterinary Market
29 mars 2022 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System, a...
LexaGene Announces Closing of Second Tranche of Investment by Strategic Institutional Investor
18 févr. 2022 12h25 HE
|
LexaGene Holdings Inc
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG)...
LexaGene Announces $6.4 Million Investment by Strategic Institutional Investor
08 févr. 2022 08h20 HE
|
LexaGene Holdings Inc
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG)...